Porcupine Tree founder Steven Wilson is one of the most acclaimed remixers in music, and we spoke to him about some of his most memorable projects.

The track marked Michael's sixth US number one, his third as a solo artist Peter Brooker/Shutterstock; Mert Alas & Marcus Piggot Taylor Swift will incorporate the melody of George Michael's 1987 hit ...

President Bola Ahmed Tinubu on Wednesday said his administration would work closely with the leadership of the National Assembly to remove political and bureaucratic bottlenecks stalling the ...

Each week, SPIN digs into the catalogs of great artists and highlights songs you might not know for our Deep Cut Friday series. “This is a song some of you have probably never heard…most of you,” Jeff ...

Forests, glaciers, and ancient fortresses pass me by as I ski through the mythical realm of Norwyn. Guitars are shredding in the background, the northern light is in the sky… But I’ve no time to gaze ...

Black Country-headquartered Higgs LLP has secured backing from private equity firm August Equity, marking a milestone in the law firm’s 150-year history. With more than 250 staff and a reputation as ...

Solid Biosciences said federal regulators have granted its fast-track designation for the company's investigational gene therapy for the treatment of a heart rhythm condition. The Food and Drug ...

An 8-year-old boy from Chicago is going viral for his exceptional music producing skills. Miles Bonham, known online as @milesmusickid, was challenged to produce a brand-new musical backing to Britney ...

"You're getting to hear one of the weird ones." Kris Allen's in Charlie Peacock's Nashville recording studio, where the 2009 American Idol winner started recording his third album Wednesday. The song ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. “I know that on this album the fast ones are some of the fastest we’ve ever written,” he told ...

SAN DIEGO, CA—Catheter ablation for ventricular arrhythmias is beneficial for patients with ischemic cardiomyopathy, affirms a new meta-analysis updated to include the VANISH2 trial results. Compared ...